Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

著者: Martin Faßnacht, Guillaume Assié, Eric Baudin, G. Eisenhofer, Christelle de la Fouchardière, Harm R. Haak, Ronald R. de Krijger, F. Porpiglia, Massimo Terzolo, Alfredo Berruti - Annals of Oncology 2020 被引用: 420

Two different primary malignancies can arise from the adrenal gland: adrenocortical carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the adrenal medulla. Both malignancies are rare. ACC has an estimated incidence of ∼0.5-2 new cases per million people per year.1,2 Phaeochromocytomas are catecholamine-producing neuroendocrine tumours arising from chromaffin cells of the adrenal medulla or extra-adrenal paraganglia. The latter are usually called paraganglioma, leading to the combined term phaeochromocytomas and paragangliomas (PPGLs).